Journal of Clinical Pharmacology

• 

  Publication Venue For

  • A Phase 1 Randomized Study of Single Intravenous Infusions of the Novel Nitroxyl Donor BMS-986231 in Healthy Volunteers..  59:717-730. 2019
  • Population Pharmacokinetic Modeling to Evaluate Standard Magnesium Sulfate Treatments and Alternative Dosing Regimens for Women With Preeclampsia..  59:374-385. 2019
  • Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia..  56:176-185. 2016
  • Rilonacept pharmacokinetics in children with systemic juvenile idiopathic arthritis..  55:39-44. 2015
  • Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AF..  54:917-927. 2014
  • In vitro and clinical investigation of the relationship between CCR5 receptor occupancy and anti-HIV activity of Aplaviroc..  48:1179-1188. 2008
  • Stereoselective bupropion hydroxylation as an in vivo phenotypic probe for cytochrome P4502B6 (CYP2B6) activity..  48:464-474. 2008
  • Simultaneous measurement of in vivo P-glycoprotein and cytochrome P450 3A activities..  46:1313-1319. 2006
  • Sensitivity of intravenous and oral alfentanil and pupillary miosis as minimally invasive and noninvasive probes for hepatic and first-pass CYP3A activity..  45:1187-1197. 2005
  • Evaluation of first-pass cytochrome P4503A (CYP3A) and P-glycoprotein activities using alfentanil and fexofenadine in combination..  45:79-88. 2005
  • Quinidine as a probe for the role of p-glycoprotein in the intestinal absorption and clinical effects of fentanyl..  44:224-233. 2004
  • Population pharmacokinetics and pharmacodynamics of zidovudine in HIV-infected infants and children..  43:133-140. 2003
  • Effects of azimilide on heart rate and ECG conduction intervals during sinus rhythm in patients with a history of atrial fibrillation..  42:388-394. 2002
  • Intraindividual variability in male hepatic CYP3A4 activity assessed by alfentanil and midazolam clearance..  39:664-669. 1999
  • Menstrual cycle variability in midazolam pharmacokinetics..  39:275-280. 1999
  • Oral ondansetron pharmacokinetics: the effect of chemotherapy..  34:767-773. 1994
  • The mechanism of action of steroid hormones: a new twist to an old tale..  33:1165-1172. 1993
  • A 19-YEAR-OLD MAN WITH ALTERED MENTAL STATUS.  32:511-519. 1992
  • A nineteen-year-old man with altered mental status..  32:511-519. 1992
  • Evaluation of the clinical pharmacology of nilvadipine in patients with mild to moderate essential hypertension..  30:425-437. 1990
  • Clinical pharmacokinetics of pinacidil, a potassium channel opener, in hypertension..  29:33-40. 1989
  • Falsely elevated urinary excretion of catecholamines and metanephrines in patients receiving labetalol therapy..  27:288-292. 1987
  • EFFECT OF PHENOBARBITAL (PB) ON PHENYTOIN (PHT) BIOTRANSFORMATION DETERMINED BY STABLE ISOTOPE TECHNIQUE.  26:544-544. 1986
  • Combined effect of bumetanide and metolazone in normal volunteers..  25:369-373. 1985
  • Treatment of chronic orthopedic pain with zomepirac..  20:385-391. 1980
  • TREATMENT OF CHRONIC ORTHOPEDIC PAIN WITH ZOMEPIRAC.  20:385-391. 1980
  • Treatment of chronic orthopedic pain with zomepirac.  20:385-391. 1980
  • SIROLIMUS DOSE-NORMALIZED TROUGHS WERE AFFECTED BY TIME POST SIROLIMUS INITIATION, CONCOMITANT TACROLIMUS THERAPY, AND MDR-1 3435C > T POLYMORPHISM IN RENAL TRANSPLANT PATIENTS WHO ARE CYP3A5 NON-EXPRESSERS 2009